BIOC - Biocept, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue5,068.6633,223.096609.909
Cost of Revenue9,345.1226,920.1114,596.158
Gross Profit-4,276.459-3,697.015-3,986.249
Operating Expenses
Research Development3,364.7472,713.3672,857.77
Selling General and Administrative13,533.511,614.6559,566.784
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-21,174.706-18,025.037-16,410.803
Income from Continuing Operations
Total Other Income/Expenses Net51.216153.648102.432
Earnings Before Interest and Taxes-21,123.49-17,871.389-16,308.371
Interest Expense482.623525.88639.547
Income Before Tax-21,606.113-18,397.269-16,947.918
Income Tax Expense7.6242.0531.608
Minority Interest---
Net Income From Continuing Ops-21,613.737-18,399.322-16,949.526
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-21,613.737-18,399.322-16,949.526
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-21,613.737-18,399.322-16,949.526